| Net income | 35.75M |
| Less: Income from discontinued operations, net of tax | |
| Income from continuing operations | |
| Depreciation and amortization | 66.89M |
| Equity in (income) loss of unconsolidated affiliates | |
| Gain on asset disposals and impairments - net | |
| Provision (benefit) from deferred taxes | 11.89M |
| Pension costs | |
| Other non-cash items | -1.66M |
| Accounts receivable | -29.66M |
| Net contracts in progress and advance billings on contracts | 53.61M |
| Accounts payable | -110.2M |
| Accrued and other current liabilities | |
| Pension liability and accrued postretirement and employee benefits | |
| Other | 34.82M |
| Net Cash Provided By (Used In) Operating Activities-Continuing Operations | 125.6M |
| Purchases of property, plant and equipment | -197.39M |
| (Increase) decrease in restricted cash and cash equivalents | |
| Net decrease in available-for-sale securities | |
| Other investing activities, net | 0 |
| Net Cash Used In Investing Activities-Continuing Operations | -183.21M |
| Payment of debt | -93.76M |
| Debt issuance costs | -8.26M |
| Increase in debt | |
| Dividend received from B&W | |
| Other financing activities, net | 0 |
| Net Cash Provided By Financing Activities-Continuing Operations | -105.92M |
| Effects of exchange rate changes on cash and cash equivalents | -861K |
| Net increase (decrease) in cash and cash equivalents | -164.39M |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period-Continuing Operations | |
| Income taxes (net of refunds) | |
| Net Cash Provided By (Used In) Operating Activities | |
| Net Cash Used In Investing Activities | |
| Net Cash Used In Financing Activities | |
| Effects of exchange rate changes on cash | |
| Net increase (decrease) in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period-Discontinued Operations | |